Hemostasis Achievement Reflecting Inflammatory Status of the Pulp Based on Cytokine Levels: A Cohort Study.
NCT ID: NCT03737682
Last Updated: 2024-08-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
41 participants
OBSERVATIONAL
2019-07-30
2023-08-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cytokines as Diagnostic Markers of Pulpal Inflammation and Their Impact on the Outcome of Vital Pulp Therapy
NCT07261761
Evaluation of Cytokines Level as an Indicator of Pulp Inflammation and Its Relation to the Success Rates of Pulpotomy in Primary Molars Affected With Proximal Versus Occlusal Decay
NCT07171229
Diagnostic Biomarkers to Correlate Molecular Changes and Inflammatory Cascade in the Dental Pulp.
NCT05464797
Pulp Inflammatory Markers and Outcome of Pulpotomy
NCT06960603
Evaluation of Dentinal Fluid for the Presence of Matrix Metalloproteinase 9 (MMP-9) in Pulpal Inflammation
NCT02967081
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
hemostasis achievement
in which hemostasis at the exposure site was achieved in five minutes were included in group A
ENzyme linked immunity-sorbet assays
Hemostasis achievement reflecting inflammatory status of the pulp based on cytokine levels
No hemostasis achievement
in which hemostasis at the exposure site couldn't be achieved in five minutes where included in group B
ENzyme linked immunity-sorbet assays
Hemostasis achievement reflecting inflammatory status of the pulp based on cytokine levels
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ENzyme linked immunity-sorbet assays
Hemostasis achievement reflecting inflammatory status of the pulp based on cytokine levels
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. patients had not used any inflammatory medications
3. primary molar teeth of these children were included based on the following clinical and radiographic criteria:
1. no clinical symptoms or evidence of pulp degeneration (pain on percussion, history of swelling or sinus tract
2. no spontaneous pain
3. no radiographic signs of internal or external resorption, widened periodontal ligament space, or furcal/periapical radiolucency
4. physiological root resorption of no more than one third the root length
5. a deep caries lesion with a likelihood of pulp exposure during caries removal
Exclusion Criteria
5 Years
7 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Samah Mohsin
principal investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cairo university
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CEBD-CU-2018-10-31
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.